Pilot - Peri-operative Beta Blockade

Completed · Phase 4

Conditions studied: Adrenergic Beta-Receptor Blockader, Troponin Levels, Cardiomyopathy, Post-surgical

In brief

Perioperative cardiac adverse events \[heart injuries caused by general anesthesia and surgical procedures\] are a significant public health issue, with more than 60,000 deaths per annum in patients having surgery for non-heart related issues. There are virtually no evidence-based medical strategies for effective prevention of these events. Preoperative drug treatment with beta blockade drugs used for high blood pressure, perioperative therapy with lipid lowering drugs such as statins, alpha-receptor agonists such as clonidine used for high blood pressure, and aspirin have all been investigated as potential mitigating treatments, but without positive clinical outcomes and, in some cases, creating more hemodynamic instabilities that result in heart injury. In light of this, investigators propose to evaluate the safety and efficacy of using increasing doses of beta blockade drugs immediately after surgery and to assess the value of high-sensitivity cardiac troponin level testing of the blood in predicting those patients who would benefit most from perioperative beta blocker therapy.

Key facts

Study ID

NCT02746575

Run by

Washington University School of Medicine

People needed

70

Starts

2015-11-01

Expected to finish

2017-10-01

Last updated by the study team

2020-01-30

Who can join

Age: 51 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >50 years
• American Society of Anesthesiologists (ASA) risk status III-IV
• Revised Cardiac Risk Index ≥2
• β-blocker naïve (not having received β-blocker within 30 days prior to surgery)
• Previously diagnosed coronary artery disease (CAD) or at high risk for CAD:
• History of peripheral vascular disease, or
• Diabetes and currently on oral anti-diabetic drug or insulin therapy, or
• Chronic renal failure (eGFR <30 m/min)
• Major non-cardiac surgery under general anesthesia

You may not qualify if…

• History of stroke
• Heart rate <55bpm
• Heart failure
• Second or third degree AV block without pacemaker
• Active asthma or COPD
• Anemia [Hb<9g/dL]
• Allergy to beta-blockade drugs
• Hemodynamic instability
• Uncontrolled hemorrhage
• Unwilling or unable to give consent for participation

Where it is running

• Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.